Peptide Receptor Radionuclide Therapy
Showing 9976 - 10000 of >10,000
Varicose Veins of Lower Limb Trial (Vitis Vinifera seed extract medication plus lifestyle modification, Lifestyle modification)
Not yet recruiting
- Varicose Veins of Lower Limb
- Vitis Vinifera seed extract medication plus lifestyle modification
- Lifestyle modification
- (no location specified)
May 8, 2023
Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute
Completed
- Chronic Myeloid Leukemia (CML)
- +4 more
- Bortezomib
- NK cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 31, 2022
Low Back Pain Trial in Natal (Exercises and dry cupping)
Not yet recruiting
- Low Back Pain
- Exercises and dry cupping
-
Natal, RN, BrazilMarcelo Cardoso de Souza
Jul 13, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Cesarean Section, Postpartum, Abdominal Pain Trial in Clermont-Ferrand, Vichy (Winback® on, Winback® off, self-massage of the
Not yet recruiting
- Cesarean Section
- +3 more
- Winback® on
- +2 more
-
Clermont-Ferrand, France
- +1 more
Jan 20, 2023
Heart Failure Trial in United States (BiovitalsHF)
Recruiting
- Heart Failure
- BiovitalsHF
-
Little Rock, Arkansas
- +8 more
Jul 21, 2022
N-Acetylcysteine asAdjuvant Therapy in Critically Ill COVID-19
Not yet recruiting
- COVID-19 Pneumonia
- (no location specified)
Aug 15, 2022
Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)
Recruiting
- Multiple Myeloma
- Selinexor (80mg/d)
- +4 more
-
Zhengzhou, Henan, China
- +4 more
Aug 16, 2022
Patients With G2019S LRRK2 Parkinson's Disease
Suspended
- Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
- Observational
-
Culver City, CaliforniaScience 37
Aug 15, 2022
Cancer Trial in Brussels (Therapeutic patient education : oral semi-structured interview, Therapeutic patient education :
Recruiting
- Cancer
- Therapeutic patient education : oral semi-structured interview
- Therapeutic patient education : booklet (passive)
-
Brussels, BelgiumCliniques universitaires Saint-Luc
Jan 5, 2022
Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)
Recruiting
- Carcinoma
- Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
-
Los Angeles, California
- +2 more
Nov 23, 2022
Glaucoma, Acupuncture, Intraocular Pressure Trial in Taichung (Acupuncture, Acupuncture )
Not yet recruiting
- Glaucoma
- +2 more
- Acupuncture
- Acupuncture placebo
-
Taichung, TaiwanChina Medical University Hospital
Mar 1, 2023
Caregiver Burden, Behavioral and Psychiatric Symptoms of Dementia, Depressive Symptoms Trial in Logan (Acceptance and Commitment
Recruiting
- Caregiver Burden
- +6 more
- Acceptance and Commitment Therapy
-
Logan, UtahUtah State University
Feb 28, 2023
Heart Failure With Reduced Ejection Fraction Trial (Left Bundle Branch Area Pacing (LBBAP), Biventricular pacing (BiV))
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Left Bundle Branch Area Pacing (LBBAP)
- Biventricular pacing (BiV)
-
Edegem, Antwerpen, Belgium
- +8 more
Oct 7, 2022
Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),
Recruiting
- Oral Squamous Cell Carcinoma
- +3 more
- Toripalimab (anti-programmed death-1 inhibitor)
- +4 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022
Xerosis Due to Atopic Dermatitis Trial in Winston-Salem (Cetaphil Pro Eczema moisturizer, Electronic interaction, GPSkin)
Active, not recruiting
- Xerosis Due to Atopic Dermatitis
- Cetaphil Pro Eczema moisturizer
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences Department of Dermatology
Dec 21, 2022
AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes
Recruiting
- Type1 Diabetes Mellitus
- +7 more
- Blood draw
- +2 more
-
Aurora, ColoradoChildren's Hospital Colorado
Jul 28, 2022
Pulmonary Sarcoidosis Trial (Hydroxychloroquine + low-dose prednisone, Prednisone)
Not yet recruiting
- Pulmonary Sarcoidosis
- Hydroxychloroquine + low-dose prednisone
- Prednisone
- (no location specified)
Feb 9, 2022
Intervention, Waitlist Control Trial (full spine corrective protocol)
Recruiting
- Intervention
- Waitlist Control
- full spine corrective protocol
-
Kelowna, British Columbia, CanadaUniversity of British Columbia Okanagan
Nov 1, 2022
Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Esophageal Squamous Cell Carcinoma, Tislelizumab, Chemoradiation Trial in Nanjing (Tislelizumab, Paclitaxel, Carboplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- Tislelizumab
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Institute & Hospital
May 24, 2022
Ovarian Cancer Trial in Rome (Tumor biopsy)
Recruiting
- Ovarian Cancer
- Tumor biopsy
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 2, 2023
Arterio-venous Fistula Trial in Denmark (Far infrared radiation)
Recruiting
- Arterio-venous Fistula
- Far infrared radiation
-
Frederiksberg, Denmark
- +8 more
Mar 17, 2022
Smoking Cessation, Electronic Cigarette Use Trial in Islamabad (Electronic Cigarette (EC), Nicotine Replacement Therapy)
Not yet recruiting
- Smoking Cessation
- Electronic Cigarette Use
- Electronic Cigarette (EC)
- Nicotine Replacement Therapy
-
Islamabad, PakistanHealth Research Consulting
Sep 26, 2023